Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Current Epidemiology projects include:

  • Enhanced modeling for NMCP Decision-making in the GMS to Accelerate Malaria Elimination (ENDGAME)
  • Reducing the Risk of Forest Malaria in the GMS: clinical trial of antimalarial chemoprophylaxis, in-depth interviews and mapping
  • Quantifying the impact of human mobility on P. falciparum malaria burden and spread of antimalarial resistance in the Greater Mekong Sub-region and Bangladesh
  • Epidemiology of malaria in northeast Thailand: a case-control study
  • Risk factors for malaria in high incidence areas of Viet Nam: a case-control study
  • Development and optimisation of Plasmodium falciparum artemisinin and partner drugs resistance maps for communication to policymakers in Southern Africa and South-East Asia
  • School and community-based student-driven dengue vector control and monitoring in Myanmar: a cluster randomized controlled trial
  • Dengue spatiotemporal epidemiology in Myanmar and Thailand
  • Impact of population movement on dengue in Thailand
  • Children's environmental health in Thailand: cohort study of pregnant women and children
  • Automated smartphone microscopy for malaria
  • GroupMappers: crowdsource mapping of communities for communicable disease surveillance in Bangladesh
  • End-to-End Data Pipeline (E2): presenting pre-publication research to policymakers

In all our projects, MORU Epidemiology works with policymakers as partners to address the scientific questions most pertinent to the disease control and elimination agendas.

We also support the following studies across the MORU network:

  • South-East Asia Clinical Trials Network (SEACTN) Wellcome Trust Flagship
  • Malaria Elimination Task Force (METF)
  • Genetic reconnaissance of malaria in the Greater Mekong Sub-region and Bangladesh (GenReMekong)
  • Molecular and in vitro surveillance of ACT partner drug efficacy in the GMS (5% MIVS-ACT)
  • Studying the impact of zoonotic disease surveillance in the Orang Asli (indigenous population) communities of Peninsular Malaysia on reducing the risk of zoonotic disease emergence